Evidence map›Paper›PMID 33123973›Full record

SynthesisHormones (Athens, Greece)2021

Diabetes is associated with increased risk for in-hospital mortality in patients with COVID-19: a systematic review and meta-analysis comprising 18,506 patients.

Leonidas Palaiodimos, Natalia Chamorro-Pareja, Dimitrios Karamanis, Weijia Li, Phaedon D Zavras, Kai Ming Chang, Priyanka Mathias, Damianos G Kokkinidis

Open access · bronzeAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Hormones (Athens, Greece), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 7 pooled it
1.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 7 syntheses or guidelines pooled it, 74 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Observational
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Leonidas PalaiodimosDivision of Hospital Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, NW Building, 8th Floor, 111 East 210th Str., Bronx, NY, 10467, USA. leonidas.palaiodimos@gmail.com.ORCID http://orcid.org/0000-0003-4682-5991
Natalia Chamorro-ParejaAlbert Einstein College of Medicine, 1400 Pelham Parkway South, Bronx, NY, 10461, USA.
Dimitrios KaramanisDepartment of Economics, University of Piraeus, 72 Ellis Str., Piraeus, 18546, Attica, Greece.
Weijia LiAlbert Einstein College of Medicine, 1400 Pelham Parkway South, Bronx, NY, 10461, USA.
Phaedon D ZavrasAlbert Einstein College of Medicine, 1400 Pelham Parkway South, Bronx, NY, 10461, USA.
Kai Ming ChangAlbert Einstein College of Medicine, 1400 Pelham Parkway South, Bronx, NY, 10461, USA.
Priyanka MathiasAlbert Einstein College of Medicine, 1400 Pelham Parkway South, Bronx, NY, 10461, USA.
Damianos G KokkinidisAlbert Einstein College of Medicine, 1400 Pelham Parkway South, Bronx, NY, 10461, USA.
Albert Einstein College of Medicine · USUniversity of Piraeus · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeInfectious diseases are more frequent and can be associated with worse outcomes in patients with diabetes. The aim of this study was to systematically review and conduct a meta-analysis of the available observational studies reporting the effect of diabetes on mortality among hospitalized patients with COVID-19.

methodsThe Medline, Embase, Google Scholar, and medRxiv databases were reviewed for identification of eligible studies. A random effects model meta-analysis was used, and I

resultsA total of 18,506 patients were included in this meta-analysis (3713 diabetics and 14,793 non-diabetics). Patients with diabetes were associated with a higher risk of death compared with patients without diabetes (OR 1.65; 95% CI 1.35-1.96; I

conclusionThis meta-analysis shows that that the likelihood of death seems to be higher in diabetic patients hospitalized with COVID-19 compared with non-diabetic patients. Further studies are needed to assess whether this association is independent or not, as well as to investigate the role of adequate glycemic control prior to infection with COVID-19.

Indexed as

SARS-CoV-2COVID-19Diabetes MellitusGlobal HealthHospital MortalityHumansPandemicsSurvival RateCOVID-19DiabetesMeta-analysisMortalityRisk factorSARS-CoV-2

Identifiers

PMID33123973
PMCPMC7595056
OpenAlexW3097734076

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.